Payton Nyquvest is the founder and CEO of Numinus, a mental health company at the forefront of the psychedelic-assisted therapy movement. He's raised over $80 million for the startup, which currently offers psychedelic-assisted therapy, traditional talk therapy, and practitioner training--and conducts research trials. In this episode, Payton shares with Megan how psychedelics saved his life and the challenges of marketing and scaling while maintaining clinical ethics and integrity.